Innovation Pharmaceuticals Inc (IPIX)
0.0015
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Innovation Pharmaceuticals Shareholders Equity (Quarterly): 1.162M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 1.162M |
June 30, 2023 | 2.039M |
March 31, 2023 | 2.716M |
December 31, 2022 | 3.081M |
September 30, 2022 | 3.421M |
June 30, 2022 | 4.73M |
March 31, 2022 | 5.815M |
December 31, 2021 | 6.945M |
September 30, 2021 | 8.297M |
June 30, 2021 | 7.509M |
March 31, 2021 | 10.20M |
December 31, 2020 | 3.436M |
September 30, 2020 | 4.669M |
June 30, 2020 | 1.462M |
March 31, 2020 | -4.471M |
December 31, 2019 | -5.617M |
September 30, 2019 | -4.544M |
June 30, 2019 | -4.129M |
March 31, 2019 | -4.285M |
December 31, 2018 | -4.236M |
September 30, 2018 | -3.972M |
June 30, 2018 | -2.151M |
March 31, 2018 | -3.715M |
December 31, 2017 | -2.879M |
September 30, 2017 | -3.167M |
Date | Value |
---|---|
June 30, 2017 | -1.464M |
March 31, 2017 | 1.183M |
December 31, 2016 | 0.136M |
September 30, 2016 | 2.131M |
June 30, 2016 | 2.964M |
March 31, 2016 | 2.866M |
December 31, 2015 | 4.254M |
September 30, 2015 | 6.035M |
June 30, 2015 | 7.024M |
March 31, 2015 | 9.764M |
December 31, 2014 | 7.116M |
September 30, 2014 | 4.544M |
June 30, 2014 | 1.206M |
March 31, 2014 | 0.9109M |
December 31, 2013 | 1.229M |
September 30, 2013 | -0.0638M |
June 30, 2013 | -5.17M |
March 31, 2013 | -6.822M |
December 31, 2012 | -7.655M |
September 30, 2012 | -7.669M |
June 30, 2012 | -7.626M |
March 31, 2012 | -7.332M |
December 31, 2011 | -8.128M |
September 30, 2011 | -7.266M |
June 30, 2011 | -7.288M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.617M
Minimum
Dec 2019
10.20M
Maximum
Mar 2021
2.596M
Average
3.251M
Median
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 4.826M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Electromed Inc | 42.54M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.667M |
Total Liabilities (Quarterly) | 5.505M |